| Genomic complexity of multiple myeloma and its clinical implications S Manier, KZ Salem, J Park, DA Landau, G Getz, IM Ghobrial Nature reviews Clinical oncology 14 (2), 100-113, 2017 | 568 | 2017 |
| Bone marrow microenvironment in multiple myeloma progression S Manier, A Sacco, X Leleu, IM Ghobrial, AM Roccaro BioMed Research International 2012, 2012 | 382 | 2012 |
| Targeting the bone marrow microenvironment in multiple myeloma Y Kawano, M Moschetta, S Manier, S Glavey, GT Görgün, AM Roccaro, ... Immunological reviews 263 (1), 160-172, 2015 | 380 | 2015 |
| Daratumumab-based treatment for immunoglobulin light-chain amyloidosis E Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, ... New England Journal of Medicine 385 (1), 46-58, 2021 | 354 | 2021 |
| Engineered nanomedicine for myeloma and bone microenvironment targeting A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ... Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014 | 281 | 2014 |
| Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma T Facon, MA Dimopoulos, A Dispenzieri, JV Catalano, A Belch, M Cavo, ... Blood, The Journal of the American Society of Hematology 131 (3), 301-310, 2018 | 280 | 2018 |
| Prognostic role of circulating exosomal miRNAs in multiple myeloma S Manier, CJ Liu, H Avet-Loiseau, J Park, J Shi, F Campigotto, KZ Salem, ... Blood, The Journal of the American Society of Hematology 129 (17), 2429-2436, 2017 | 262 | 2017 |
| Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020 | 250 | 2020 |
| Regulation of microRNAs in cancer metastasis JMC Bouyssou, S Manier, D Huynh, S Issa, AM Roccaro, IM Ghobrial Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (2), 255-265, 2014 | 225 | 2014 |
| Ide-cel or standard regimens in relapsed and refractory multiple myeloma P Rodriguez-Otero, S Ailawadhi, B Arnulf, K Patel, M Cavo, AK Nooka, ... New England Journal of Medicine 388 (11), 1002-1014, 2023 | 188 | 2023 |
| Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma S Manier, J Park, M Capelletti, M Bustoros, SS Freeman, G Ha, J Rhoades, ... Nature communications 9 (1), 1691, 2018 | 179 | 2018 |
| A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial T Facon, MA Dimopoulos, N Meuleman, A Belch, M Mohty, WM Chen, ... Leukemia 34 (1), 224-233, 2020 | 149 | 2020 |
| Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression M Bustoros, R Sklavenitis-Pistofidis, J Park, R Redd, B Zhitomirsky, ... Journal of Clinical Oncology 38 (21), 2380, 2020 | 142 | 2020 |
| CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation AM Roccaro, Y Mishima, A Sacco, M Moschetta, YT Tai, J Shi, Y Zhang, ... Cell reports 12 (4), 622-635, 2015 | 136 | 2015 |
| The cancer glycome: carbohydrates as mediators of metastasis SV Glavey, D Huynh, MR Reagan, S Manier, M Moschetta, Y Kawano, ... Blood reviews 29 (4), 269-279, 2015 | 127 | 2015 |
| Role of endothelial progenitor cells in cancer progression M Moschetta, Y Mishima, I Sahin, S Manier, S Glavey, A Vacca, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 26-39, 2014 | 125 | 2014 |
| Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model MR Reagan, Y Mishima, SV Glavey, Y Zhang, S Manier, ZN Lu, ... Blood, The Journal of the American Society of Hematology 124 (22), 3250-3259, 2014 | 122 | 2014 |
| The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma SV Glavey, S Manier, A Natoni, A Sacco, M Moschetta, MR Reagan, ... Blood, The Journal of the American Society of Hematology 124 (11), 1765-1776, 2014 | 120 | 2014 |
| Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant TH Mouhieddine, AS Sperling, R Redd, J Park, M Leventhal, CJ Gibson, ... Nature communications 11 (1), 2996, 2020 | 117 | 2020 |
| Targeting MYC in multiple myeloma KK Jovanović, C Roche-Lestienne, IM Ghobrial, T Facon, B Quesnel, ... Leukemia 32 (6), 1295-1306, 2018 | 115 | 2018 |
